MENOPUR

LOE Approaching

menotropins

BLASUBCUTANEOUSINJECTABLE
Approved
Oct 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
14

Mechanism of Action

MENOPUR, administered for 7 to 20 days, produces ovarian follicular growth and maturation in women who do not have primary ovarian failure. Treatment with MENOPUR in most instances results only in follicular growth and maturation. When sufficient follicular maturation has occurred, hCG must be…

Clinical Trials (5)

NCT06997900Phase 2Recruiting

Menopur And Rekovelle Combination Study Version 2.0

Started Jul 2025
200 enrolled
IVFControlled Ovarian SimulationFertility Disorders
NCT04814940N/AWithdrawn

Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility Treatment

Started Sep 2022
0
Infertility, Female
NCT04876300N/ACompleted

MEDAM (Menopur Retrospective Data prograM)

Started Nov 2021
11,488 enrolled
Infertility, Female
NCT04902131Phase 1Completed

A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women

Started Nov 2021
95 enrolled
Infertility, Female
NCT04163458Phase 3Completed

Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)

Started Oct 2019
405 enrolled
Infertility